位置:首页 > 蛋白库 > AGLD_HALVD
AGLD_HALVD
ID   AGLD_HALVD              Reviewed;         624 AA.
AC   D4GUA0; A4VB68;
DT   25-JAN-2012, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 1.
DT   03-AUG-2022, entry version 52.
DE   RecName: Full=Glycosyltransferase AglD;
DE            EC=2.4.1.-;
DE   AltName: Full=Archaeal glycosylation protein D;
GN   Name=aglD; OrderedLocusNames=HVO_0798;
OS   Haloferax volcanii (strain ATCC 29605 / DSM 3757 / JCM 8879 / NBRC 14742 /
OS   NCIMB 2012 / VKM B-1768 / DS2) (Halobacterium volcanii).
OC   Archaea; Euryarchaeota; Stenosarchaea group; Halobacteria; Haloferacales;
OC   Haloferacaceae; Haloferax.
OX   NCBI_TaxID=309800;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, PATHWAY, AND GENE NAME.
RC   STRAIN=DS2 / DS70;
RX   PubMed=17996897; DOI=10.1016/j.jmb.2007.10.042;
RA   Abu-Qarn M., Yurist-Doutsch S., Giordana A., Trauner A., Morris H.R.,
RA   Hitchen P., Medalia O., Dell A., Eichler J.;
RT   "Haloferax volcanii AglB and AglD are involved in N-glycosylation of the S-
RT   layer glycoprotein and proper assembly of the surface layer.";
RL   J. Mol. Biol. 374:1224-1236(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 29605 / DSM 3757 / JCM 8879 / NBRC 14742 / NCIMB 2012 / VKM
RC   B-1768 / DS2;
RX   PubMed=20333302; DOI=10.1371/journal.pone.0009605;
RA   Hartman A.L., Norais C., Badger J.H., Delmas S., Haldenby S., Madupu R.,
RA   Robinson J., Khouri H., Ren Q., Lowe T.M., Maupin-Furlow J.,
RA   Pohlschroder M., Daniels C., Pfeiffer F., Allers T., Eisen J.A.;
RT   "The complete genome sequence of Haloferax volcanii DS2, a model
RT   archaeon.";
RL   PLoS ONE 5:E9605-E9605(2010).
RN   [3]
RP   MUTAGENESIS OF ASP-110; ASP-112; ASP-133; GLY-137; SER-138; ARG-139;
RP   ASP-173; GLN-175; CYS-176; GLY-177; PHE-178; LYS-179; ASP-195 AND ASP-201.
RC   STRAIN=DS2 / DS70;
RX   PubMed=20585355; DOI=10.1155/2010/315108;
RA   Kaminski L., Eichler J.;
RT   "Identification of residues important for the activity of Haloferax
RT   volcanii AglD, a component of the archaeal N-glycosylation pathway.";
RL   Archaea 2010:315108-315108(2010).
RN   [4]
RP   FUNCTION.
RC   STRAIN=H53;
RX   PubMed=21091511; DOI=10.1111/j.1365-2958.2010.07405.x;
RA   Guan Z., Naparstek S., Kaminski L., Konrad Z., Eichler J.;
RT   "Distinct glycan-charged phosphodolichol carriers are required for the
RT   assembly of the pentasaccharide N-linked to the Haloferax volcanii S-layer
RT   glycoprotein.";
RL   Mol. Microbiol. 78:1294-1303(2010).
RN   [5]
RP   FUNCTION IN GLYCOSYLATION OF FLAGELLINS, AND DISRUPTION PHENOTYPE.
RC   STRAIN=H53;
RX   PubMed=22730124; DOI=10.1128/jb.00731-12;
RA   Tripepi M., You J., Temel S., Onder O., Brisson D., Pohlschroder M.;
RT   "N-glycosylation of Haloferax volcanii flagellins requires known Agl
RT   proteins and is essential for biosynthesis of stable flagella.";
RL   J. Bacteriol. 194:4876-4887(2012).
CC   -!- FUNCTION: Involved in the assembly of a N-linked pentasaccharide that
CC       decorates the S-layer glycoprotein and flagellins. Catalyzes the
CC       addition of the mannose found at position 5 of the pentasaccharide to
CC       its own distinct dolichol phosphate carrier.
CC       {ECO:0000269|PubMed:17996897, ECO:0000269|PubMed:21091511,
CC       ECO:0000269|PubMed:22730124}.
CC   -!- PATHWAY: Cell surface structure biogenesis; S-layer biogenesis.
CC       {ECO:0000269|PubMed:17996897}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- DISRUPTION PHENOTYPE: Mutants exhibit defective or limited motility.
CC       {ECO:0000269|PubMed:22730124}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 2 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AM698042; CAM91696.1; -; Genomic_DNA.
DR   EMBL; CP001956; ADE04998.1; -; Genomic_DNA.
DR   RefSeq; WP_004044138.1; NC_013967.1.
DR   AlphaFoldDB; D4GUA0; -.
DR   SMR; D4GUA0; -.
DR   STRING; 309800.C498_14743; -.
DR   CAZy; GT2; Glycosyltransferase Family 2.
DR   PRIDE; D4GUA0; -.
DR   EnsemblBacteria; ADE04998; ADE04998; HVO_0798.
DR   GeneID; 8924085; -.
DR   KEGG; hvo:HVO_0798; -.
DR   eggNOG; arCOG00897; Archaea.
DR   HOGENOM; CLU_474611_0_0_2; -.
DR   OMA; LRDHQCG; -.
DR   OrthoDB; 9352at2157; -.
DR   BioCyc; MetaCyc:MON-19290; -.
DR   UniPathway; UPA00977; -.
DR   Proteomes; UP000008243; Chromosome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016757; F:glycosyltransferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0045232; P:S-layer organization; IEA:UniProtKB-UniPathway.
DR   CDD; cd04188; DPG_synthase; 1.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR035518; DPG_synthase.
DR   InterPro; IPR001173; Glyco_trans_2-like.
DR   InterPro; IPR022791; L-PG_synthase/AglD.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   Pfam; PF00535; Glycos_transf_2; 1.
DR   Pfam; PF03706; LPG_synthase_TM; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   TIGRFAMs; TIGR00374; TIGR00374; 2.
PE   1: Evidence at protein level;
KW   Cell membrane; Glycosyltransferase; Membrane; Reference proteome;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN           1..624
FT                   /note="Glycosyltransferase AglD"
FT                   /id="PRO_0000415388"
FT   TRANSMEM        260..280
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        285..305
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        381..401
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        427..447
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        496..518
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        532..552
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        556..576
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        587..607
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        201
FT                   /evidence="ECO:0000305"
FT   MUTAGEN         110
FT                   /note="D->A,E: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:20585355"
FT   MUTAGEN         112
FT                   /note="D->E: Change in activity."
FT                   /evidence="ECO:0000269|PubMed:20585355"
FT   MUTAGEN         112
FT                   /note="D->N: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:20585355"
FT   MUTAGEN         133
FT                   /note="D->A: No change in activity."
FT                   /evidence="ECO:0000269|PubMed:20585355"
FT   MUTAGEN         137
FT                   /note="G->A: No change in activity."
FT                   /evidence="ECO:0000269|PubMed:20585355"
FT   MUTAGEN         138
FT                   /note="S->A: No change in activity."
FT                   /evidence="ECO:0000269|PubMed:20585355"
FT   MUTAGEN         139
FT                   /note="R->A,E,K,M: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:20585355"
FT   MUTAGEN         173
FT                   /note="D->E: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:20585355"
FT   MUTAGEN         173
FT                   /note="D->N: No change in activity."
FT                   /evidence="ECO:0000269|PubMed:20585355"
FT   MUTAGEN         175
FT                   /note="Q->A: No change in activity."
FT                   /evidence="ECO:0000269|PubMed:20585355"
FT   MUTAGEN         176
FT                   /note="C->A: No change in activity."
FT                   /evidence="ECO:0000269|PubMed:20585355"
FT   MUTAGEN         177
FT                   /note="G->A: No change in activity."
FT                   /evidence="ECO:0000269|PubMed:20585355"
FT   MUTAGEN         178
FT                   /note="F->A: No change in activity."
FT                   /evidence="ECO:0000269|PubMed:20585355"
FT   MUTAGEN         179
FT                   /note="K->A: No change in activity."
FT                   /evidence="ECO:0000269|PubMed:20585355"
FT   MUTAGEN         195
FT                   /note="D->A: No change in activity."
FT                   /evidence="ECO:0000269|PubMed:20585355"
FT   MUTAGEN         201
FT                   /note="D->A,N: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:20585355"
FT   MUTAGEN         201
FT                   /note="D->E: No change in activity."
FT                   /evidence="ECO:0000269|PubMed:20585355"
SQ   SEQUENCE   624 AA;  66990 MW;  EEAF1CCBB682D8C0 CRC64;
     MGRPTERRPA AATAAGVEVS VVLPAYNEAR TIENTVRVTV ETLESFLPAD AFEVIVAEDG
     CDDETPEIAD RLAAEDDRIR HYHSDDRLGR GGALERAFEA ARGDTLVYFD TDLATDMRHL
     EELVERVRSG EYDAATGSRW MPDRVADRPR KRGVPSRAYN GLVRLFLRSD LRDHQCGFKA
     FSREAFEALR DDVEDNHWFW DTEMLVRAQR AGFRVAEFPV DWEPKGDTKV DLVRDILGMG
     SQILRTWWQL TVRPRITRRV TIVAGLLLTV LALALMTLYI DPSEVISVLG DADPALVAAA
     AVIYVVSWPL RGIRYREILR ELGYREKAGF LTGAIFISQT GNLVFPARAG DAVRAYVVKA
     RRNIPYPSGF ASLAVERVFD LLTIAGLAGV VLVGLAATGG LDDIATVLAT GVSGGSVDVS
     ADDVRTAAYV ATGVGVVAIL GVLGIALSAR ADRNVVRAFV GRFSSDSYVE LVAGVIEQFV
     SDLQAVAGNR AAFGRVGLTS LAIWTVDVVT AVVVLLALGV DIDPVVLVGV SFFAVSVGNL
     AKVLPLSPGG VGLYEIAFTV FMAALAPVTP AAALAAAVLD HAVKNAVTIV GGVGSMLSLN
     VSLTTAVEES AEVRDREHEL ADSK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024